Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 2nd October 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Update on Bluetongue vaccination
Regulation change for Bluetongue-free areas

Bluetongue laws have changed for England and Scotland, and are set to change for Wales, to allow the use of approved inactivated vaccines in Bluetongue-free areas, on the basis of Veterinary Risk Assessments.

In England, the Bluetongue (Amendment) Regulations 2012 came into effect last month (24 August) to permit the use of inactivated Bluetongue vaccines in Bluetongue-free areas. A General Licence has been issued to protect against Bluetongue serotypes 1, 2, 4 and 8.

Scotland's Bluetongue (Scotland) Order 2012 came into effect at the same time as England and permits inactivated Bluetongue vaccinations against all serotypes within Bluetongue-free areas.

Next week (10 October), the Bluetongue (Wales) (Amendment) Regulations 2012 will come into effect, permitting the use of inactivated Bluetongue vaccinations in Bluetongue-free areas against all serotypes.

The use of voluntary vaccination against Bluetongue remain illegal in both Northern Ireland and the Republic of Ireland.

Regulations for live attenuated vaccines remain unaltered, and must not be used due to the risk of reversion to virulence and subsequent disease spread. Live attenuated vaccines do not have marketing authorisations for use in the UK.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.